Stem Cell Reports

Scope & Guideline

Leading the Charge in Stem Cell Breakthroughs

Introduction

Delve into the academic richness of Stem Cell Reports with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2213-6711
PublisherCELL PRESS
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationSTEM CELL REP / Stem Cell Rep.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139

Aims and Scopes

Stem Cell Reports is dedicated to advancing the understanding and application of stem cell biology in various therapeutic contexts. The journal emphasizes innovative methodologies and interdisciplinary approaches to explore the complexities of stem cells and their potential in regenerative medicine.
  1. Stem Cell Biology and Dynamics:
    The journal focuses on the fundamental biology of stem cells, including their self-renewal, differentiation, and the regulatory mechanisms involved. It often employs mathematical modeling and experimental techniques to elucidate these processes.
  2. Innovative Therapeutic Applications:
    There is a significant emphasis on translating stem cell research into clinical applications, particularly for regenerative medicine, including therapies for various diseases and conditions such as cardiac, orthopedic, and neurological disorders.
  3. Interdisciplinary Approaches:
    The journal promotes research that integrates various fields such as bioengineering, immunology, and computational biology to enhance the understanding and manipulation of stem cells for therapeutic purposes.
  4. Ethical and Technical Frameworks:
    Stem Cell Reports explores the ethical implications and technical advancements in fetal therapy and other stem cell applications, ensuring that research is conducted responsibly and with consideration for ethical standards.
  5. Emerging Technologies in Stem Cell Research:
    The journal highlights advancements in technologies such as 3D scaffolding, machine learning, and organoid development, which are pivotal in improving stem cell therapies and understanding their mechanisms.
The journal has shown a dynamic evolution in its focus, reflecting the rapid advancements in stem cell research. Recent publications indicate several emerging themes that are becoming increasingly relevant in the field.
  1. Application of Machine Learning and Computational Modelling:
    Recent papers emphasize the use of machine learning and quantitative modeling to analyze stem cell behavior and dynamics, reflecting a trend towards data-driven research methodologies that enhance predictive capabilities in stem cell applications.
  2. Prenatal and Fetal Therapies:
    There is a growing interest in prenatal therapies, particularly for congenital conditions, as evidenced by multiple recent publications. This trend underscores the potential of stem cell therapies to address developmental disorders early in life.
  3. Immunomodulation and MSCs:
    The immunomodulatory properties of mesenchymal stem cells (MSCs) are increasingly recognized, particularly in the context of treating inflammatory diseases and enhancing the efficacy of therapies, indicating a shift towards understanding immune interactions.
  4. 3D Bioprinting and Scaffold Engineering:
    Innovative approaches such as 3D bioprinting and engineered scaffolds are gaining prominence, showcasing their potential to optimize stem cell therapies and tissue engineering applications, further bridging the gap between basic research and clinical application.
  5. COVID-19 Related Research:
    The impact of the COVID-19 pandemic has led to a surge in research exploring the use of stem cells in treating related complications, particularly acute respiratory distress syndrome (ARDS), highlighting the adaptability of stem cell applications in response to global health challenges.

Declining or Waning

While Stem Cell Reports has consistently explored a wide range of themes, certain areas appear to be declining in prominence as newer topics gain traction. This section highlights those themes that have seen reduced focus in recent publications.
  1. Traditional Stem Cell Sources:
    Research focusing exclusively on traditional stem cell sources, such as embryonic stem cells, has seen a decline in favor of more innovative approaches like induced pluripotent stem cells (iPSCs) and adult stem cells, which offer more ethical and practical advantages.
  2. Basic Stem Cell Characterization Studies:
    There is a noticeable decrease in papers solely dedicated to basic characterization of stem cells without direct application to therapeutic contexts. The trend is shifting towards studies that connect characterization with specific clinical applications.
  3. Niche Microenvironment Studies:
    While the role of stem cell microenvironments is crucial, there has been a waning interest in purely observational studies of niche interactions without integrating these findings into therapeutic strategies or technological advancements.

Similar Journals

Genes & Diseases

Unlocking the secrets of genes to combat diseases.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

Journal of Biological Engineering

Transforming Ideas into Impactful Discoveries
Publisher: BMCISSN: 1754-1611Frequency: 1 issue/year

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

CELL PROLIFERATION

Advancing the Frontiers of Cellular Research
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

DIFFERENTIATION

Connecting Researchers to Transformative Discoveries
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

Current Stem Cell Research & Therapy

Cultivating Knowledge in Stem Cell Applications
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-888XFrequency: 8 issues/year

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Elevating the Study of In Vitro Dynamics
Publisher: SPRINGERISSN: 1071-2690Frequency: 10 issues/year

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

STEM CELLS AND DEVELOPMENT

Unraveling the Mysteries of Development and Regeneration
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

CYTOTECHNOLOGY

Empowering Researchers: Unleashing Potential in Biomedical Innovation.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

STEM CELLS

Fostering knowledge in the evolving world of stem cells.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

Cells

Illuminating the World of Cells Through Groundbreaking Research
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.